Chong-Rui Xu Wen-Zhao Zhong Qing Zhou Xu-Chao Zhang Jin-Ji Yang Yi-Long Wu
10.1111/1759-7714.12382
Thorac Cancer
2017 Jan;8(1):51-53.
egfr tki heterogeneity lung cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/27801981/
Carcinoma, Non-Small-Cell Lung / drug therapy Drug Resistance, Neoplasm ErbB Receptors / genetics Liver Neoplasms / drug therapy Lung Neoplasms / drug therapy Proto-Oncogene Proteins c-met / genetics
Carcinoma, Non-Small-Cell Lung / drug therapy Drug Resistance, Neoplasm ErbB Receptors / genetics Liver Neoplasms / drug therapy Lung Neoplasms / drug therapy Proto-Oncogene Proteins c-met / genetics Case Reports Adult Carcinoma, Non-Small-Cell Lung / genetics Gefitinib Genetic Heterogeneity Humans Liver Neoplasms / genetics Liver Neoplasms / secondary Lung Neoplasms / genetics Male Protein Kinase Inhibitors / administration & dosage Protein Kinase Inhibitors / therapeutic use Quinazolines / administration & dosage Quinazolines / therapeutic use Treatment Outcome Protein Kinase Inhibitors Quinazolines EGFR protein, human ErbB Receptors MET protein, human Proto-Oncogene Proteins c-met Gefitinib
PMC5217905
27801981
Heterogeneity of the resistance to gefitinib treatment in a non-small cell lung cancer patient with active epidermal growth factor receptor mutation
2017